CEO and Shareholder
Ramon Bosser provides more than 25 years’ experience in the pharma and biotech industry, where he has gained extensive R&D, managerial and entrepreneurial skills. Previous to joining Origo Biopharma he was co-founder and COO at Spherium, a biotech company bringing projects from the academia to clinical development in gastrointestinal, dermatology, pain, and nephrology indications. Prior to that he was Director of Program Management at Almirall for more than 10 years, where he leaded more than 10 novel drug development projects in respiratory, gastrointestinal, rheumatology, erectile dysfunction and dermatology indications. Three projects reached worldwide market, and two of them were sold for more than $ 1 billion to Astra Zeneca. He was also involved in negotiations with partners and led two alliances with American companies.